Felix Meyer
- Otorhinolaryngology top 2%
- Oncology top 10%
- PARP inhibition in cancer therapy 4
- Cancer Cells and Metastasis 2
-
- Cancer, Hypoxia, and Metabolism 2
-
- DNA Repair Mechanisms 10
- PI3K/AKT/mTOR signaling in cancer 3
- CRISPR and Genetic Engineering 3
- Cell death mechanisms and regulation 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Kerstin BorgmannAnna DubrovskaAlexander SchulzCordula PetersenMalte KriegsThorsten RieckmannEkkehard DikomeyChia‐Jung Busch
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Felix Meyer
19 papers receiving 643 citations
Peers
Comparison fields: 5 of 74
- Otorhinolaryngology 139
- Oncology 289
- Cancer Research 159
- Molecular Biology 341
- Pulmonary and Respiratory Medicine 117
Countries citing papers authored by Felix Meyer
This map shows the geographic impact of Felix Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Meyer more than expected).
Fields of papers citing papers by Felix Meyer
This network shows the impact of papers produced by Felix Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Meyer. The network helps show where Felix Meyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Felix Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 31 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 24 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 210 | |
| 19 | 2019 | 6 | |
| 20 | 2013 | 250 |
About Felix Meyer
Felix Meyer is a scholar working on Oncology, Physical Therapy, Sports Therapy and Rehabilitation and Otorhinolaryngology, having authored 20 papers that have together received 646 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), PARP inhibition in cancer therapy (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), CRISPR and Genetic Engineering (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer Cells and Metastasis (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Otorhinolaryngology (139 citations), Oncology (289 citations) and Cancer Research (159 citations). Felix Meyer has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Kerstin Borgmann, Anna Dubrovska, Alexander Schulz, Cordula Petersen, Malte Kriegs, Thorsten Rieckmann, Ekkehard Dikomey, Chia‐Jung Busch, Silke Tribius and Tobias Grob. Their work appears in journals such as Cancers, Frontiers in Oncology, Radiotherapy and Oncology, Journal of Clinical Medicine and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.